Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIIM: Cytokines and Treg Cells in Migraine
NCT06426316Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Open-label trial (4 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Regulatory T cell levels. Started Jun 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06426316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06426316.